Trial Profile
A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2020
Price :
$35
*
At a glance
- Drugs Abametapir (Primary) ; Benzyl alcohol
- Indications Pediculosis
- Focus Adverse reactions
- Sponsors Dr Reddys Laboratories; Hatchtech
- 16 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Dec 2013 New trial record